Idiopathic Immune Complex-Mediated Glomerulonephritis
1 clinical trials · Condition
◉ Watch Idiopathic Immune Complex-Mediated Glomerulonephritis
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy Study of OMS906 in Patients With C3G and ICGN (NCT06209736) | Omeros Corporation | 2024-03-01 |
Track Idiopathic Immune Complex-Mediated Glomerulonephritis automatically
Every clearance here is in the API, with alerts when new ones post.